Literature DB >> 21093609

Chemical probes for biological systems.

Ricard Garcia-Serna1, Jordi Mestres.   

Abstract

According to the latest definition in use by the NIH Molecular Libraries Screening Centers Network, a compound to be nominated as a chemical probe should have, on the one hand, an affinity below 100 nM for the primary target and, on the other hand, at least tenfold selectivity against related targets. Taking drugs as the ultimate product of an affinity and selectivity optimization process, it is found that only 14.4% of them would actually qualify as chemical probes under those criteria. Therefore, if chemical probes are expected to give rise to new medicines, strict adherence to the current probe definition might result in many compounds of potential therapeutic interest being overlooked.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 21093609     DOI: 10.1016/j.drudis.2010.11.004

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  7 in total

1.  Identifying mechanism-of-action targets for drugs and probes.

Authors:  Elisabet Gregori-Puigjané; Vincent Setola; Jérôme Hert; Brenda A Crews; John J Irwin; Eugen Lounkine; Lawrence Marnett; Bryan L Roth; Brian K Shoichet
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

Review 2.  Global phenotypic screening for antimalarials.

Authors:  W Armand Guiguemde; Anang A Shelat; Jose F Garcia-Bustos; Thierry T Diagana; Francisco-Javier Gamo; R Kiplin Guy
Journal:  Chem Biol       Date:  2012-01-27

3.  Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy.

Authors:  Kevin J Frankowski; Michael P Hedrick; Palak Gosalia; Kelin Li; Shenghua Shi; David Whipple; Partha Ghosh; Thomas E Prisinzano; Frank J Schoenen; Ying Su; S Vasile; Eduard Sergienko; Wilson Gray; Santosh Hariharan; Loribelle Milan; Susanne Heynen-Genel; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H Smith; John M Streicher; Marc G Caron; Lawrence S Barak; Laura M Bohn; Thomas D Y Chung; Jeffrey Aubé
Journal:  ACS Chem Neurosci       Date:  2012-01-20       Impact factor: 4.418

4.  Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome.

Authors:  Suman Rao; Deepak Gurbani; Guangyan Du; Robert A Everley; Christopher M Browne; Apirat Chaikuad; Li Tan; Martin Schröder; Sudershan Gondi; Scott B Ficarro; Taebo Sim; Nam Doo Kim; Matthew J Berberich; Stefan Knapp; Jarrod A Marto; Kenneth D Westover; Peter K Sorger; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2019-04-11       Impact factor: 8.116

5.  Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome.

Authors:  J Mestres; S A Seifert; T I Oprea
Journal:  Clin Pharmacol Ther       Date:  2011-10-05       Impact factor: 6.875

6.  Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification.

Authors:  Pedro J Ballester; Martina Mangold; Nigel I Howard; Richard L Marchese Robinson; Chris Abell; Jochen Blumberger; John B O Mitchell
Journal:  J R Soc Interface       Date:  2012-08-29       Impact factor: 4.118

Review 7.  Composition and applications of focus libraries to phenotypic assays.

Authors:  Anne Mai Wassermann; Luiz M Camargo; Douglas S Auld
Journal:  Front Pharmacol       Date:  2014-07-24       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.